Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8
Titel:
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8
Auteur:
Kearns, Ann E. Northfelt, Donald W. Dueck, Amylou C. Atherton, Pamela J. Dakhil, Shaker R. Rowland, Kendrith M. Fuloria, Jyotsna Flynn, Patrick J. Dentchev, Todor Loprinzi, Charles L.